The observation of suggestive clinical symptoms in a patient suffering from a Gougerot-Sjögren syndrome led to a search for a cryoglobulin. Unusual physico-chemical features of this cryoglobulin were discovered, using standard electrophoresis, immunoelectrophoresis, immunofixation and electroimmunotransfer. The main unusual finding was that the cryoprecipitate was made up of a biclonal IgMic associated to polyclonal IgG. Therefore, we suggest that this new form of cryoglobulin be classified as a subtype lib, thus distinguishing two subtypes in the usual classification.
Introduction
Cryoglobulins have been classified into three types according to the characteristics of the constituting Ig (1): type I corresponds to the presence of a single monoclonal Ig; type II is formed of a monoclonal Ig and polyclonal Ig, frequently a monoclonal rheumatoid IgM complexed with polyclonal IgG; type III, in which only polyclonal Ig are found, in low concentrations. The first two types are mostly encountered in Waldenström macroglobulinaemia, myeloma, other lymphoproliferative diseases and immune disorders such as the GougerotSjögren syndrome. The third type is mostly encountered in auto-immune or infectious diseases (2) . Certain cases of type II and type III are considered by some authors as the so-called "mixed essential cryoglobulins", many of which are now associated with hepatitis C virus infection and mostly contain IgG (either monoclonal, bi-or multiclonal). They have been largely described and reviewed in recent years (3, 4) . In contrast, biclonal IgM evolving towards monoclonal IgM, associated to a primary Gougerot-Sjögren syndrome has not been yet described, to our knowledge. 
Materials and Methods

Case history
A 65-year-old woman with primary Sjören syndrome known for 10 years, and assessed by labial salivary glands biopsy, was admitted at the hospital at the end of December 1994 because of a white, soft and painless lower limb oedema, pitting and rising up to the lumbar region. Clinical examination showed a blood pressure at 21.3/12.0 kPa, a 7 kg weight increase (present weight is 52.5 kg). Raynaud's phenomenon, xerostomia and a definite xerophthalmia were present. Further clinical examination was non-contributive.
Biological features revealed an incomplete nephrotic syndrome, with proteinuria (4.45 g/24 h), hypoprotidaemia (43 g/1) and hypoalbuminaemia (20.8 g/1). Urinary cytobacteriological tests showed a microscopic haematuria; electrophoresis of urinary proteins showed a predominance of albumin (77.8%). Renal function was normal. -Glutamyltransferase was increased to 5 times the reference value.
A mixed, type II cryoglobulinaemia was present, the composition of which will be detailed below.
Immunological tests yielded the following results: presence of antinuclear antibodies at the 1/200 dilution, with an Ml speckled aspect (by indirect immunofluorescence technique on Hep. 2 cells), and an SSA specificity (55 Units); other antibodies against soluble nuclear antigen, e. g. SSB, Sm, RNP, Scl 70 and Jo-1 2 ) were absent. Anti-mitochondria antibodies were present at 1/100, with an M2 aspect. Hepatitis B surface (HBs) antigen was not detected, serologic tests for hepatitis C were negative. Hepatitis C virus was absent, as shown by polymerase chain reaction. Complete haematological investigations including osteomedullary biopsy did not reveal any sign of tumoural development.
Renal biopsy showed a cryoglobulin related damage. There were neither extra-capillary crescents, nor tubulo-interstitial consequences. Anti-IgG and anti-IgM antisera revealed granular, mostly parietal positive staining corresponding to the cryoglobulin type.
Corticosteroid therapy (1 mg/kg · d, or 50 mg/d) was started, associated to saluretic furosemide (Lasilix®, 60 mg/d) and anti-hypertensive nicardifine (Loxen 50®, 3 tablets, 150 mg per day).
Evolution was favourable with regression of oedema, weight loss of 10kg. After a 2 month corticosteroid therapy, proteinuria dropped to 1.5 g/24 h, total serum protein raised to 60 g/1, as well as serum albumin (34 g/1). Cryoglobulin was still present. Corticosteroid therapy was then progessively reduced until a total span of 5 months. At the end of this treatment, proteinuria was almost physiological (0.15 g/24 h) and cryoglobulin had disappeared.
Four months after stopping corticosteroid therapy, a recurrence of the nephrotic syndrome was observed, with proteinuria (1.75g/ 24 h) and hypoalbuminaemia (28 g/1). Cryoglobulin reappeared, with an apparently different content, which was analyzed as described below. Haematological tests still revealed no sign of lymphoma.
Corticosteroid therapy (50 mg/d) was reintroduced allowing a drop of the proteinuria to 0.70 g/24 h, after 3 months. An alternate corticosteroid therapy was then started for 2 years: 50 mg/kg · d, one every other day. At the present time, cryoglobulin is persistent, but nephrotic syndrome has not reappeared.
Sera
Two specimens were collected, on 23 December 1994 and 15 September 1995 (at the time of nephrotic syndrome recurrence).
Blood was drawn in a dry sampling vial and kept at 37 °C until complete clotting. Then serum was separated, still at 37 °C.
Screening for monoclonal immunoglobulins
Cellulose acetate electrophoresis was performed with whole sera at 37 °C in order to look for monoclonal immunoglobulins. All material used were from Sebia (92130 Issy-les-Moulineaux, France).
Cryoglobulin detection
After adding sodium azide (100 mg/1), sera were stored at 4 °C for 24 hours, then visually examined for cryoprecipitate.
Study of cryoprecipitates
The cryoprecipitates were isolated and washed three times with NaCl 150 mmol/1 at 4 °C according to the classical technique (1). They were strictly maintained at a temperature between 37 and 40 °C until analysis. Purity of cryoprecipitates was checked by immunoelectrophoresis, using an antiserum against human serum total proteins (5).
Typing of the cryoglobulins was performed by immunoelectrophoresis (6), immunofixation (7) and electroimmunotransfer (8) .
The serum sampled on 23 December 1994 yielded a cryoprecipitate, termed A; serum sampled on 15 September 1995 yielded cryoprecipitate B.
Results and Discussion
The known Gougerot-Sj gren syndrome of this patient has been complicated with a cryoglobulinaemia after a 10 year evolution, as described in frequent cases (2), 20% to 40% of the cases according to some authors (12, 14) . This cryoglobulinaemia has been responsible for membrano-proliferative glomerulonephritis, as the origin of the nephrotic syndrome.
The aetiologic investigations of this Gougerot-Sj gren syndrome associated to a type II cryoglobulinaemia included the search for a lymphoproliferative syndrome: clinical examination found no peripheral lymphadenopathy, nor did thoraco-abdominal computer tomography scan find any profound adenopathy. Bone marrow aspirate and biopsy evidenced no malignant tumoural infiltrate. Collagen disease could not be evidenced; a viral C infection could have been at the origin of the cryoglobulinaemia, but hepatitis C serology and hepatitis C virus PCR tests were negative.
The hypothesis of a primary biliary cirrhosis has been raised in light of both the increase of γ-glutamyltransferase to 5 times the reference value and the presence of type M2 anti-mitochondria antibodies.
A hepatic biopsy was done but the normal aspect of the biliary ducts did not lead to this diagnostic.
As for therapy, a favourable evolution has been induced by corticoids, but its initial 5 months duration proved to be insufficient, with recurrence of nephrotic syndrome and cryoglobulinaemia 4 months after. A lengthened corticosteroid therapy for at least one year was then started again.
Although no monoclonal immunoglobulin was detected by electrophoresis, an abundant cryoprecipitate was found in both sera after 24 h at 4 °C. The precipitation temperature was determined to be between 37 and 30 °C in both cases, which is not very common (9) . This case confirms that temperature is more important than quantity, as underlined by the same authors (9), because it explains typical clinical features despite the low concentration of this cryoglobulin. Immunoelectrophoresis ( fig.  1 , anti-human serum total protein antiserum) demonstrated the absence of albumin, thus proving the purity of the cryoprecipitate. Anti-IgG, anti-IgM, anti-κ light chains (bound and free) and anti-λ light chains (bound and free) revealed the presence of a monoclonal IgMic and of polyclonal IgG. This located the cryoglobulin in type II of the current classification (1).
Immunoelectrophoresis of cryoprecipitate A exhibited a more abundant non-specific precipitate at the well cathodic edge than did that of the second precipitate. Consequently, immunofixation was performed to further explore these aspects. IgM monomers. Therefore, we were led to conclude that both monoclonal IgM were polymers.
Cryoprecipitate A is composed of two monoclonal common polymeric IgMK, or biclonal IgM (according to usual techniques), and polyclonal IgG, an observation that has never been described before to our knowledge. The closest resembling case was cited by Musset et al. and corresponded in fact to a pentaclonal Ig (l IgG + 4 IgM), which was detectable in the corresponding whole serum. Thus, we propose subdividing type II of the current cryoglobulin classification into:
-type Ha, which would include cryoglobulins formed of one monoclonal Ig and polyclonal Ig (corresponding to type II of the previous classification);
-type lib, which would be defined as cryoglobulins made up of two (or more) monoclonal Ig (multiclonal Ig) and polyclonal Ig. As suggested by previous authors (3), and by a frequent observation done in current practice, a progressive spreading of the cases could be distinguished inside this subtype, from bi-to tri-to multiclonal Ig, the latter could be the closest category to type III, whatever the concentrations found.
In our present case, cryoglobulin isolated from the first sample belongs to type lib, cryoglobulin from the second sample is of type Ila.
The evolution within 9 months of a biclonal component of a cryoglobulin towards a monoclonal component seems interesting. Although it has been suggested (12) that oligoclonal lymphocyte expansion could precede a malignant state, there are no significant works, to our knowledge, stating that a change from circulating bi-or triclonal Ig to monoclonal Ig is a meaningful prognostic criterion. However, it has to be noted that, in our present case, the reappearance of a monoclonal cryoglobulin is correlative to the recurrence of the nephrotic syndrome, while it was initially biclonal, and had disappeared with corticosteroid therapy. The absence of any lymphoproliferative syndrome proves that this evolution does not correspond to a malignant dysglobulinaemia. It would rather make it classify as an "associated dysglobulinaemia", according to the authors' classification (5): "associated dysglobulinaemia" include all cases which are associated to an immunological disorder. This is consistent with the statement according to which lymphoma is a rare complication of primary Sjögren's syndrome (13) .
As for the theoretical aspects of the cryoprecipitation phenomenon, our observation would tend to prove that in this case, the different Ig are not bound together. As a matter of fact, our results clearly show (even more evidently than in usual cases of type II cryoglobulins) that the two monoclonal IgM and the polyclonal IgG migrate independently: the different length and curve of the two IgG and IgM arcs imply two distinct fractions; the obvious difference in aspect and migration position of the immunofixation bands also suggest non-complexed types of molecules. Thus, they do not seem to be bound in any manner. Otherwise, we would get a similar aspect of the IgM and the IgG fractions, probably as a mixture or indefinite aspect in terms of arc length and curve in immunoelectrophoresis, and in the narrowness or broadness of the immunofixation bands.
So, as a recent work tends to show (14), we think that the Ig components of mixed (type II) cryoglobulins coprecipitate independently, without any bonding. Thus, the reason for the cryoprecipitation phenomenon must be searched for in the structure of each molecule implied. The rather significant volume of the cryoprecipitate compared to the extremely low concentration of Ig (undetectable by electrophoresis) would suggest the presence of a non-protein substance. The type of binding involved in the cryoprecipitate, either of the antigenantibody type or resulting from another mechanism could not be explored on these specimens.
Conclusion
A new evolutive aspect of a cryoglobulinaemia is described in a patient with Gougerot-Sjögren syndrome.
The serum drawn at first exhibits a peculiar type II cryoglobulin, made of a biclonal IgMK and of polyclonal IgG. Nine months later, the biclonal IgMK has evolved to a monoclonal IgMK, raising the question of the prognostic meaning of such observations.
It is suggested that the classification of cryoglobulins be modified, dividing type II into type Ha for monoclonal Ig and type lib for bi or multiclonal Ig.
This work also shows that cryoprecipitation is not necessarily an antigen-antibody phenomenon and that its mechanism more probably proceeds from a structural basis of some Ig.
